Latest in Agricole Sticks Guidance
Sort by
111 items
-
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.Business - CNBC - 6 days ago -
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.Business - CNBC - October 30 -
Carvana raises 2024 earnings guidance after topping Wall Street's Q3 expectations
Carvana said its adjusted EBITDA would be "significantly above the high end" of its previous target of $1 billion to $1.2 billion.Business - CNBC - 6 days ago -
We reiterate our 1 rating on Microsoft despite its softer guidance — here's why
The numbers look different this quarter due the company re-segmenting a few businesses, but overall there's not much to complain about.Business - CNBC - 6 days ago -
Peloton raises its full-year profit guidance, but expects the holiday quarter to be softer than expected
Peloton's cash flows are improving, but it's expecting to sell fewer bikes and treadmills during its holiday quarter than Wall Street expected.Business - CNBC - 5 days ago -
Linde falls after its guidance fails to wow the market. We've seen this movie before
Shares of the industrial gas supplier dropped around 3% in a down market.Business - CNBC - 5 days ago -
Super Micro shares plunge 17% after company says no timetable for annual results, issues weak guidance
Super Micro, the embattled server maker, reported preliminary first-quarter results on Tuesday.Business - CNBC - 16 hours ago -
Novo Nordisk shares jump 8% after Wegovy sales beat expectations
Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.Business - CNBC - 6 hours ago -
CVS posts mixed results, holds off on guidance in Joyner's first earnings report as CEO
CVS expects elevated medical costs to continue to pressure its performance this year, "and as a result we are not providing a formal outlook at this time."Business - CNBC - 1 hour ago -
Trump’s ex-chief of staff says he is a fascist and would govern as a dictator
Four-star US General John Kelly’s claims were reported in blockbuster comments to The New York TimesWorld - Financial Times - October 23 -
Investors pile into emerging-market funds that cut out China
Demand for ‘ex-China’ strategies soar as tensions with west linger, despite recent stock reboundWorld - Financial Times - October 23 -
UK ministers explore using break clauses in asylum housing contracts
Home Office aims to revise terms or terminate after being ‘shocked’ by private companies’ profitsWorld - Financial Times - October 23